Progranulin expression in advanced human atherosclerotic plaque

Atherosclerosis

Volumn 206, Issue 1, 2009, Pages 102-108

  Kojima, Yoji ^a   Ono, Koh ^a   Inoue, Katsumi ^b   Takagi, Yasushi ^a   Kikuta, Ken ichiro ^a   Nishimura, Masaki ^a   Yoshida, Yoshinori ^a   Nakashima, Yasuhiro ^a   Matsumae, Hironobu ^a   Furukawa, Yutaka ^c   Mikuni, Nobuhiro ^a   Nobuyoshi, Masakiyo ^d   Kimura, Takeshi ^a   Kita, Toru ^a   Tanaka, Makoto ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KURASHIKI CENTRAL HOSPITAL   (Japan)

^c KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^d KOKURA MEMORIAL HOSPITAL   (Japan)

Author keywords

Atherosclerosis; IL 8; Inflammation; Smooth muscle cell

Indexed keywords

INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PROGRANULIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATHEROSCLEROTIC PLAQUE; CANCER CELL CULTURE; CAROTID ENDARTERECTOMY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; SMOOTH MUSCLE FIBER;

ATHEROSCLEROSIS; CAROTID ARTERY DISEASES; CELL LINE; CELL MOVEMENT; CHEMOKINE CCL2; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; TUMOR NECROSIS FACTOR-ALPHA; TUNICA INTIMA;

EID: 68949200351     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.02.017     Document Type: Article

References (28)

1. Lusis A.J. Atherosclerosis. Nature 407 (2000) 233-241
2. Berliner J., Leitinger N., and Watson A. Oxidized lipids in atherogenesis: formation, destruction and action. Thromb Haemost 78 (1997) 195-199
3. Williams K.J., and Tabas I. The response-to-retention hypothesis of atherogenesis reinforced. Curr Opin Lipidol 9 (1998) 471-474
4. Witztum J.L., and Berliner J.A. Oxidized phospholipids and isoprostanes in atherosclerosis. Curr Opin Lipidol 9 (1998) 441-448
5. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
6. Stemme S., Faber B., Holm J., et al. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA 92 (1995) 3893-3897
7. Rifai N., and Ridker P.M. Inflammatory markers and coronary heart disease. Curr Opin Lipidol 13 (2002) 383-389
8. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
9. Sangiorgi G., Rumberger J.A., Severson A., et al. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol 31 (1998) 126-133
10. He Z., and Bateman A. Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. J Mol Med 81 (2003) 600-612
11. Liu Y., Xi L., Liao G., et al. Inhibition of PC cell-derived growth factor (PCDGF)/granulin-epithelin precursor (GEP) decreased cell proliferation and invasion through downregulation of cyclin D and CDK4 and inactivation of MMP-2. BMC Cancer 7 (2007) 22
12. Jones M.B., Spooner M., and Kohn E.C. The granulin-epithelin precursor: a putative new growth factor for ovarian cancer. Gynecol Oncol 88 (2003) S136-S139
13. Pizarro G.O., Zhou X.C., Koch A., et al. Prosurvival function of the granulin-epithelin precursor is important in tumor progression and chemoresponse. Int J Cancer 120 (2007) 2339-2343
14. Monami G., Gonzalez E.M., Hellman M., et al. Proepithelin promotes migration and invasion of 5637 bladder cancer cells through the activation of ERK1/2 and the formation of a paxillin/FAK/ERK complex. Cancer Res 66 (2006) 7103-7110
15. Guerra R.R., Kriazhev L., Hernandez-Blazquez F.J., and Bateman A. Progranulin is a stress-response factor in fibroblasts subjected to hypoxia and acidosis. Growth Factors 25 (2007) 280-285
16. Eriksen J.L., and Mackenzie I.R. Progranulin: normal function and role in neurodegeneration. J Neurochem 104 (2008) 287-297
17. Zhu J., Nathan C., Jin W., et al. Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell 111 (2002) 867-878
18. Tolkatchev D., Malik S., Vinogradova A., et al. Structure dissection of human progranulin identifies well-folded granulin/epithelin modules with unique functional activities. Protein Sci 17 (2008) 711-724
19. He Z., Ong C.H., Halper J., and Bateman A. Progranulin is a mediator of the wound response. Nat Med 9 (2003) 225-229
20. Matsumae H., Yoshida Y., Ono K., et al. CCN1 knockdown suppresses neointimal hyperplasia in a rat artery balloon injury model. Arterioscler Thromb Vasc Biol 28 (2008) 1077-1083
21. Horie T., Ono K., Kinoshita M., et al. TG-interacting factor is required for the differentiation of preadipocytes. J Lipid Res 49 (2008) 1224-1234
22. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
23. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
24. Garcia-Touchard A., Henry T.D., Sangiorgi G., et al. Extracellular proteases in atherosclerosis and restenosis. Arterioscler Thromb Vasc Biol 25 (2005) 1119-1127
25. Simonini A., Moscucci M., Muller D.W.M., et al. IL-8 is an angiogenic factor in human coronary atherectomy tissue. Circulation 101 (2000) 1519-1526
26. Yue T.L., Wang X., Sung C.P., et al. Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells. Circ Res 75 (1994) 1-7
27. Gerszten R.E., Garcia-Zepeda E.A., Lim Y.C., et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398 (1999) 718-723
28. Leclercq A., Houard X., Philippe M., et al. Involvement of intraplaque hemorrhage in atherothrombosis evolution via neutrophil protease enrichment. J Leukoc Biol 82 (2007) 1420-1429